PMO-155 Low pre-treatment HBsAG plasma levels, on therapy HBsAG levels decline and IP-10 concentrations increase predict response to treatment in tolerant children with chronic hepatitis B
PMO-155 Low pre-treatment HBsAG plasma levels, on therapy HBsAG levels decline and IP-10 concentrations increase predict response to treatment in tolerant children with chronic hepatitis B